Arrowhead Pharmaceuticals (ARWR) Stock Price: $110 Target And Buy Rating

By Amit Chowdhry ● Jun 12, 2022
  • The shares of Arrowhead Pharmaceuticals Inc (NASDAQ: ARWR) have received a $110 price target from H.C. Wainwright. These are the details.

The shares of Arrowhead Pharmaceuticals Inc (NASDAQ: ARWR) have received a $110 price target from H.C. Wainwright. And H.C. Wainwright analyst Patrick Trucchio increased the price target on Arrowhead from $100 while maintaining a “Buy” rating on the shares.

Trucchio adjusted the rating while following the upbeat R&D day. And Arrowhead provided significant detail on pulmonary targeted RNA interference therapeutics candidates to target muco-obstructive diseases, obstructive inflammatory pulmonary diseases, and idiopathic pulmonary fibrosis.

Disclaimer: This content is intended for informational purposes. Before making any investment, you should do your own analysis.